2026 NPPES data Pharmacotherapy Pharmacist NPI 1386656809 RPH
Verify on CMS →

ROBIN JOHN, RPH

Pharmacotherapy Pharmacist in TOPPENISH, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
520
Medicare Part D claims · 29 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: ROBIN JOHN, RPH is a Pharmacotherapy Pharmacist ([object Object]) practicing in TOPPENISH, Washington with a Medicare Part D prescribing footprint of 520 claims across 29 beneficiaries — 33% brand-name prescribing .

What stands out: ROBIN JOHN, RPH filed 520 Medicare Part D claims in 2023 across TOPPENISH, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ROBIN JOHN, RPH at a glance

Quality data not reported

NPI registry status

Active

Issued 08/13/2006

NPI 1386656809

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

520 31% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in Washington

How Pharmacotherapy Pharmacist compares to other specialties among Washington providers

Washington providers

Pharmacotherapy Pharmacist share within Washington

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBIN JOHN, RPH is a Pharmacotherapy Pharmacist provider practicing in TOPPENISH, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: RPH. NPI: 1386656809. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBIN JOHN, RPH appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding RPH credentials at 401 BUSTER RD, TOPPENISH, WA, 98948, with a listed phone of (509) 865-2102. NPI 1386656809 was issued on 08/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what JOHN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 520 prescription claims written by this provider, covering 29 Medicare beneficiaries and totaling roughly $117K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

401 BUSTER RD
TOPPENISH, WA 98948

Provider Details

NPI 1386656809
Specialty Pharmacotherapy Pharmacist
Credentials RPH
Gender Female
NPI Issued 08/13/2006

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to ROBIN JOHN, RPH. To verify ROBIN JOHN, RPH's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ROBIN JOHN, RPH — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 520 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

520
Total Claims
$117K
Total Drug Cost
29
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
522
Total Day Supply
15,594
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$114K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.77

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
77
Metformin Hcl Er
Metformin Hcl
65
Amlodipine Besylate
54
Jardiance
Empagliflozin
45
Ozempic
Semaglutide
40
Levemir Flexpen
Insulin Detemir
27
Lisinopril
25
Carvedilol
24
Rosuvastatin Calcium
18
Losartan Potassium
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How ROBIN JOHN, RPH fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

ROBIN JOHN, RPH's 520 claims are above the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as JOHN.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBIN JOHN, RPH's specialty?
ROBIN JOHN, RPH specializes in Pharmacotherapy Pharmacist and practices in TOPPENISH, Washington. Credentials: RPH.
How much does ROBIN JOHN, RPH prescribe under Medicare Part D?
In 2023, ROBIN JOHN, RPH wrote 520 Medicare Part D claims totaling $117K in drug costs for 29 beneficiaries.
Where is ROBIN JOHN, RPH located?
ROBIN JOHN, RPH is located at 401 BUSTER RD, TOPPENISH, WA, 98948. Phone: (509) 865-2102.
What is ROBIN JOHN, RPH's NPI number?
ROBIN JOHN, RPH's National Provider Identifier (NPI) is 1386656809, issued on 08/13/2006.
Does ROBIN JOHN, RPH prescribe more brand-name or generic drugs?
ROBIN JOHN, RPH's prescribing is 33% brand-name and 67% generic drugs by claim count, with $114K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does ROBIN JOHN, RPH prescribe most often?
Based on 2023 Medicare Part D data, ROBIN JOHN, RPH's most frequently prescribed drugs include Atorvastatin Calcium, Metformin Hcl Er, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBIN JOHN, RPH accept Medicare?
ROBIN JOHN, RPH appears in CMS Medicare data with 520 Part D claims and 29 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBIN JOHN, RPH's credentials?
ROBIN JOHN, RPH's NPI is 1386656809 with credentials RPH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology